<?xml version="1.0" encoding="UTF-8"?>
<p id="Par18">Evaluation of hematologic toxicity according to age subgroups (Table 
 <xref rid="Tab3" ref-type="table">3</xref>) revealed that elderly patients had the same median days of aplasia as the younger cohort. Concerning non-hematopoietic toxicity, there were no significant differences in all parameters, namely infection and mucositis. This was also verified when adjusting to the dose of melphalan.
</p>
